Diverse effects of eosinophil cationic granule proteins on IMR-32 nerve cell signaling and survival

American Journal of Respiratory Cell and Molecular Biology

Volumn 33, Issue 2, 2005, Pages 169-177

  Morgan, Ross K ^b   Costello, Richard W ^a   Durcan, Niamh ^b   Kingham, Paul J ^b   Gleich, Gerald J ^b   McLean, W Graham ^b   Walsh, Marie Therese ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b NONE

Author keywords

Apoptosis; MAP kinases; Plasticity

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR BASIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; AKT1 PROTEIN, HUMAN; BCL2 RELATED PROTEIN A1; BCL2-RELATED PROTEIN A1; COMPLEMENTARY DNA; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ARTICLE; ASTHMA; BFL 1 GENE; CELL ADHESION; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENTERITIS; ENZYME PHOSPHORYLATION; GENE; HUMAN; HUMAN CELL; INFLAMMATION; NERVE CELL PLASTICITY; NERVE REGENERATION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; NERVE CELL; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; UPREGULATION;

APOPTOSIS; BASE SEQUENCE; CELL LINE; CELL SURVIVAL; DNA, COMPLEMENTARY; EOSINOPHIL MAJOR BASIC PROTEIN; EOSINOPHIL-DERIVED NEUROTOXIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; NEURONS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 24344453022     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0056OC     Document Type: Article

References (36)

1. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663.
2. Martin LB, Kita H, Leiferman KM, Gleich GJ. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 1996;109:207-215.
3. Walsh GM. Eosinophil granule proteins and their role in disease. Curr Opin Hematol 2001;8:28-33.
4. Klion A, Nutman T. The role of eosinophils in host defence against helminth parasites. J Allergy Clin Immunol 2004;113:30-37.
5. Rosenberg HF, Tenen DG, Ackerman SJ. Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc Natl Acad Sci USA 1989;86:4460-4464.
6. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
7. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204.
8. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004;305:1773-1776.
9. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, McElwain K, McElwain S, Friedman S, Broide DH. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004;113:551-560.
10. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-1769.
11. Costello RW, Schofield BH, Kephart GM, Gleich GJ, Jacoby DB, Fryer AD. Localization of eosinophils to airway nerves and effect on nerve M2 muscannic receptor function. Am J Physiol Lung Cell Mol Physiol 1997;273:L93-L103.
12. Kingham PJ, McLean WG, Sawatzky DA, Walsh M-T, Costello RW. Adhesion-dependent interactions between eosinophils and cholinergic nerves. Am J Physiol Lung Cell Mol Physiol 2002;282:L1229-L1238.
13. Sawatzky DA, Kingham PJ, Durcan N, McLean WG, Costello RW. Eosinophil-induced release of acetylcholine from differentiated cholinergic nerve cells. Am J Physiol Lung Cell Mol Physiol 2003;285: L1296-L1304.
14. Sawatzky DA, Kingham PJ, Court E, Kumaravel B, Fryer AD, Jacoby DB, McLean WG, Costello RW. Eosinophil adhesion to cholinergic nerves via 1CAM-1 and VCAM-1 and associated eosinophil degranulation. Am J Physiol Lung Cell Mol Physiol 2002;282:L1279-L1288.
15. Walsh M-T, Curran DR, Kingham PJ, Morgan RK, Durcan N, Gleich GJ, McLean WG, Costello RW. Effect of eosinophil adhesion on intracellular signaling in cholinergic nerve cells. Am J Respir Cell Mol Biol 2004;30:333-341.
16. Kingham PJ, McLean WG, Walsh M-T, Fryer AD, Gleich GJ, Costello RW. Effects of eosinophils on nerve cell morphology and development: the role of reactive oxygen species and p38 MAP kinase. Am J Physiol Lung Cell Mol Physiol 2003;285:L915-L924.
17. Morgan RK, Kingham PJ, Walsh M-T, Curran DC, Durcan N, McLean WG, Costello RW. Eosinophil adhesion to cholinergic IMR-32 cells protects against induced neuronal apoptosis. J Immunol 2004;173:5963-5970.
18. Gleich GJ, Loegering DA, Mann KG, Maldonado JE. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest 1976;57:633-640.
19. Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci USA 1986;83:3146-3150.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
21. Zhu Y, Culmsee C, Klumpp S, Krieglstein J. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinasel, 2 signaling pathways. Neuroscience 2004;123:897-906.
22. Wassom DL, Loegering DA, Solley GO, Moore SB, Schooley RT, Fauci AS, Gleich GJ. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest 1981;67:651-661.
23. Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 2000;26:79-82.
24. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979;123:2925-2927.
25. Rothenberg ME. Eosinophilic gastrointestinal disorders. J Allergy Clin Immunol 2004;113:11-28.
26. Kim KC, Gleich GJ, Lee MK. Two eosinophil granule proteins, eosinophil peroxidase and major basic protein, inhibit mucin release from hamster tracheal surface epithelial cells in primary culture. Inflamm Res 1999;48:314-317.
27. Shenoy NG, Gleich GJ, Thomas LL. Eosinophil major basic protein stimulates neutrophil superoxide production by a class IA phosphoinositide 3-kinase and protein kinase C-zeta-dependent pathway. J Immunol 2003;171:3734-3741.
28. Shahana S, Kampf C, Roomans GM. Effects of the cationic protein poly-L-arginine on airway epithelial cells in vitro. Mediators Inflamm 2002;11:141-148.
29. Mattson MP, Camandola S. NF-kappaB in nerve plasticity and neurodegenerative disorders. J Clin Invest 2001;107:247-254.
30. Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRLI) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000;192:1069-1074.
31. Bowdish DME, Davidson DJ, Speert DP, Hancock REW. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol 2004;172:3758-3765.
32. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, Rabe KF, Hiemstra PS. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003;171:6690-6696.
33. Duzgunes N, De Ilarduya CT, Simoes S, Zhdanov RI, Konopka K, Pedroso de Lima MC. Cationic liposomes for gene delivery: novel cationic lipids and enhancement by proteins and peptides. Curr Med Chem 2003;10:1213-1220.
34. Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmerman N, Foster PS, Rothenberg ME. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol 2001;2:353-360.
35. Nassenstein C, Braun A, Erpenbeck VJ, Lommatzsch M, Schmidt S, Krug N, Luttmann W, Renz H, Virchow JC Jr. The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma. J Exp Med 2003;198:455-467.
36. Fryer AD, Jacob DB. Plasticity of cholinergic and tachykinergic nerves: the convergence of the twain. Am J Physiol Lung Cell Mol Physiol 2002;283:L907-L908.